Register for email alerts and news feeds:
This journal | BMJ Group
rss
The most recent version of this article was published on 1 January 2009

J Med Genet. Published Online First: 19 September 2008. doi:10.1136/jmg.2008.059485
Copyright © 2008 by the BMJ Publishing Group Ltd.

Original articles

Site-dependent differences in both prelamin A and adipogenic genes in subcutaneous adipose tissue of patients with type 2 familial partial lipodystrophy

David Araujo-Vilar 1*, Giovanna Lattanzi 2, Blanca González-Méndez 1, Ana Teresa Costa-Freitas 1, Daniel Prieto 3, Marta Columbaro 2, Elisabetta Mattioli 2, Berta Victoria 1, Noelia Martínez-Sánchez 1, Alia Ramazanova 1, Máximo Fraga 1, Andrés Beiras 1, Jerónimo Forteza 1, Lourdes Domínguez-Gerpe 1, Carlos Calvo 1 and Joaquín Lado-Abeal 1

1 University of Santiago de Compostela, Spain
2 IGM-CNR Unit of Bologna c/o IOR, Bologna, Italy
3 Hospital Clinico Universitario de Santiago de Compostela, Spain

* To whom correspondence should be addressed. E-mail: david.araujo{at}usc.es.

Accepted 22 August 2008


Abstract

Type 2 familial partial lipodystrophy (FPLD2) is characterized by loss of fat in the limbs and buttocks and results from mutations in the LMNA gene. The aim of this study was to evaluate the role of several genes involved in adipogenesis in order to better understand the underlying mechanisms of regional loss of subcutaneous adipose tissue (scAT) in patients with FPLD2. Subjects and Methods: Seven patients with FPLD2 and ten control healthy subjects were studied. Minimal model was used to calculate the insulin sensitivity (IS).. scAT was obtained from abdomen and thigh by biopsy. Relative gene expression was quantified by real time RT-PCR in a Light Cycler 2.0. Prelamin A western blot analysis was carried out on scAT. Prelamin A nuclear localisation was determined using immunofluorescence. Adipocyte nuclei were examined by electron microscopy. Results: Patients with FPLD2 were found to have significantly lower IS. The expression of LMNA was similar in both groups. The expression of PPARG2, RB1, CCND3 and LPL, in thigh, but not in abdomen scAT, was significantly reduced (67%, 25%, 38% and 66% respectively) in FPLD2 patients. Significantly higher levels of prelamin A were detected in peripheral scAT of FPLD2 patients. Defects in the peripheral heterochromatin and a nuclear fibrous dense lamina were present in adipocytes of FPLD2 patients. Conclusions: In FPLD2 subjects, prelamin A accumulation in peripheral scAT is associated with a reduced expression of several genes involved in adipogenesis, which could perturb the balance between proliferation and differentiation in adipocytes leading to less efficient tissue regeneration.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Genetics jobs

Genetics jobs